Xinliang Chen

1.1k citations
43 papers · 812 indexed · 1 hit paper · h-index 15

Xinliang Chen

39 papers receiving 802 citations

Hit Papers

Hesperetin relieves cisplatin-induced acute kidney injury...194201920262021202350100150

Peers

Xinliang Chen
Comparison fields: 5 of 105
  • Biomaterials 179
  • Rheumatology 114
  • Obstetrics and Gynecology 58
  • Rehabilitation 47
  • Surgery 268
Replace M. Yat Tse with:
M. Yat Tse Canada
Jiawei Shi China
Elif Güzel Türkiye
Ming Shi China
Binghai Chen China
Wanjin Tang United States
Silvia Sancilio Italy
Poulami Basu India
Jianqiao Hong China
Xinliang Chen relative to M. Yat Tse Canada M. Yat Tse's profile →
Citations per field
00.5×6.7×
M. Yat Tse · 1×
Citations per year

Countries citing papers authored by Xinliang Chen

Since Specialization
Citations

This map shows the geographic impact of Xinliang Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinliang Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinliang Chen more than expected).

Fields of papers citing papers by Xinliang Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinliang Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinliang Chen. The network helps show where Xinliang Chen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Xinliang Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xinliang Chen Line = papers co-authored together Xinliang Chen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20243
2 20241
3 202339
4 202310
5 202335
6 202343
7 20231
8 20222
9 202150
10 202027
11
Hesperetin relieves cisplatin-induced acute kidney injury by mitigating oxidative stress, inflammation and apoptosisbreakdown →
2019194
12 201819
13 20170
14 201614
15 201512
16 201441
17 20134
18 20119
19 201112
20 200912

About Xinliang Chen

Xinliang Chen is a scholar working on Rheumatology, Surgery and Biomaterials, having authored 43 papers that have together received 812 indexed citations. Recurring topics across this work include Pelvic floor disorders treatments (14 papers), Anorectal Disease Treatments and Outcomes (11 papers), Tissue Engineering and Regenerative Medicine (7 papers), Hernia repair and management (7 papers), Pelvic and Acetabular Injuries (6 papers), Electrospun Nanofibers in Biomedical Applications (6 papers), Nanoplatforms for cancer theranostics (3 papers) and Wound Healing and Treatments (2 papers). The work is most often cited by research in Biomaterials (179 citations), Rheumatology (114 citations) and Obstetrics and Gynecology (58 citations). Xinliang Chen has collaborated with scholars based in China, United States and Portugal. Frequent co-authors include Yazhen Li, Jingbo Huang, Xinxin Ci, Wei Wei, Wenguo Cui, Qimanguli Saiding, Huaifang Li, Bruno Sarmento, Guanchun Wang and Yi Xiang. Their work appears in journals such as SHILAP Revista de lepidopterología, Advanced Functional Materials and Journal of Controlled Release.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026